1min snip

Money Talks from The Economist cover image

Money Talks: Why weight-loss drugs will reshape the world

Money Talks from The Economist

NOTE

Impact of Novo Nordisk on Danish Economy

Novo Nordisk, the pharmaceutical giant behind groundbreaking weight loss drugs, has become a cornerstone of the Danish economy, driving growth and preventing recession. The company's success has made it the most valuable company in Europe, with around 3% of Danes employed or benefiting from it. The majority of buyers of Novo Nordisk's weight loss drugs are American, paying over $1,000 per month for treatment. The company's significant USD revenue has influenced Denmark's central bank to keep interest rates low to prevent the currency from appreciating against the euro.

00:00

Get the Snipd
podcast app

Unlock the knowledge in podcasts with the podcast player of the future.
App store bannerPlay store banner

AI-powered
podcast player

Listen to all your favourite podcasts with AI-powered features

Discover
highlights

Listen to the best highlights from the podcasts you love and dive into the full episode

Save any
moment

Hear something you like? Tap your headphones to save it with AI-generated key takeaways

Share
& Export

Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more

AI-powered
podcast player

Listen to all your favourite podcasts with AI-powered features

Discover
highlights

Listen to the best highlights from the podcasts you love and dive into the full episode